Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Black cohosh

This article was originally published in The Tan Sheet

Executive Summary

Australia's Therapeutic Goods Association is requiring a warning on all products containing black cohosh that reads, "Warning: Black cohosh may harm the liver in some individuals. Use under the supervision of a healthcare professional," the country's government announces Feb. 9. TGA reviewed the safety of black cohosh to find 47 cases of liver reactions worldwide, including nine cases in Australia. "Considering the widespread use of black cohosh, the incidence of liver reaction appears to be very low," TGA states. However, four of the nine Australians who suffered liver problems were hospitalized and two required transplants. New products must comply with the requirement from the time of their launch, but existing products have a 12-month phase-in period...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099105

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel